EAU 2018

EAU 2018: The Impact of Surgical Strategy in Robot-Assisted Partial Nephrectomy: Should we Treat Anterior Tumors with Transperitoneal Access and Posterior Tumors with Retroperitoneal Access?

Copenhagen, Denmark (UroToday.com) Available comparisons between trans- [tRAPN] and retroperitoneal robot-assisted partial nephrectomy [rRAPN] are scarce and affected by relevant selection bias. The aim of this study was to compare perioperative morbidity, renal function and positive surgical margins [PSM] after tRAPN and rRAPN focusing on the position of the tumour.

EAU 2018: Perioperative Outcomes of Aspirin Use in Partial Nephrectomy

Copenhagen, Denmark (UroToday.com) Rising incidence of cardiovascular disease has led to increases in the patient population using anti-platelet therapy who require urologic surgery. The authors sought to study perioperative outcomes for those undergoing partial nephrectomy (PN) while taking or not taking perioperative aspirin (pASA).

EAU 2018: Quality of Life of Spouses Living with Men Undergoing Androgen Deprivation Therapy for Prostate Cancer

Introduction and Objectives: Men with prostate cancer undergoing androgen deprivation therapy (ADT) offered a supervised group-based exercise program as standard of care at our department. A previous questionnaire survey by the spouses to these men, show that the quality of life (Qol) of > 40% of the spouses are reduced. Therefore, the objective of this study was to investigate what factors that affect the experienced Qol by the spouses of men with prostate cancer undergoing ADT and attending a supervised group-based exercise program. And in which way we as Health professionals can help reduce the factors that affect quality of life in a negative way.

EAU 2018: Prostate Specific Membrane Antigen (PSMA) Expression in Transitional Cell Carcinoma (TCC) – Who Puts The S in PSMA?

Copenhagen, Denmark (UroToday.com) PSMA (prostate-specific membrane antigen) is a unique molecular specific to prostate tissue that has enabled novel imaging for prostate cancer, specifically in the setting of biochemical recurrence. PSMA-targeted PET scans, used for both diagnosis and potentially treatment, have been increasingly utilized in the setting of early biochemical recurrence, and in some cases, for staging purposes. As such, it has revolutionized prostate cancer management.

EAU 2018: Is There Finally an Increasing Survival of Patients With Urinary Bladder Cancer? A Nationwide Study in Sweden 1997–2016

Copenhagen, Denmark (UroToday.com) Bladder cancer has been one malignancy that has not seen significant improvement in outcomes over the past few decades. Despite the introduction of neoadjuvant chemotherapy and its slight benefit in appropriate patients, bladder cancer as a whole has remained relatively unchanged.

EAU 2018: Utilization and Outcomes of Chemoprophylaxis for the Prevention of Venous Thromboembolism Following Radical Cystectomy: A Population-Based Study

Copenhagen, Denmark (UroToday.com) Venous thromboembolic events (VTE) following radical cystectomy (RC) can be disastrous. A large body of evidence points to the increased risk that these patients have after extensive pelvic surgery, and prospective evidence has recently shown that immediate post-operative chemical VTE prophylaxis followed by 4 weeks of postoperative prophylaxis significantly decreases VTE rates with minimal increases in bleeding risks. 

EAU 2018: Disease and Patient’s Characteristics In Elderly (≥75 Years) Treated with Radical Cystectomy: Results of a Large Multicentre Retrospective Series

Copenhagen, Denmark (UroToday.com) The median age at diagnosis of bladder cancer is 70 years, and this age is shifting upward in many parts of the world with ageing populations. Hence, radical cystectomy (RC), which is the gold standard for muscle-invasive bladder cancer (MIBC), needs to be carefully monitored for safety in the elderly. That said, a large body of observational evidence does seem to show that RC is safe in the elderly, and should not be denied to a patient solely based on age.